(Q82667897)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Assessment of the impact of renal impairment on systemic exposure of new molecular entities: evaluation of recent new drug applications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Y Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

L Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S Abraham

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S Apparaju

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

T-C Wu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J M Strong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S Xiao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A J Atkinson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

K E Thummel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J S Leeder

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

C Lee

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

G J Burckart

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

L J Lesko

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S-M Huang

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

19 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

305-311

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of chronic kidney disease in the United States

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

The effect of chronic renal failure on hepatic drug metabolism and drug disposition

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Emerging evidence of the impact of kidney disease on drug metabolism and transport

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Drug Metabolism and Active Drug Metabolites in Renal Failure

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Effects of renal failure on drug transport and metabolism

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

The Effect of Renal Failure on Hepatic Drug Clearance

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Uremic toxins: what are they? An integrated overview of pathobiology and classification

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Effects of indoxylsulfate on the in vitro hepatic metabolism of various compounds using human liver microsomes and hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Characterization of hepatic cytochrome p4503A activity in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Hemodialysis acutely improves hepatic CYP3A4 metabolic activity

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Clinical pharmacology studies in patients with renal impairment: past experience and regulatory perspectives

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Unmasking the dynamic interplay between efflux transporters and metabolic enzymes.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.208

7 January 2021

Identifiers

DOI

10.1038/CLPT.2008.208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020495%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference